To examine if male patients with SARS-CoV-2 infection have more membrane-bound or shedded ACE2, immunoblotting was performed on uEVs isolated from a cohort of COVID-19 patients (> 60 yr), and from a cohort of young healthy males from a previous study [87]. This evidence concerns the gene ACE2 and COVID-19.